Not applicableStudy completedNCT04879316What this trial is testingEnergy for LymphocytesWho this might be right forNon-small Cell Lung CancerProgression, Disease Hôpital Cochin 144
Not applicableStudy completedNCT02385604What this trial is testingThe Predictive Value of CT-PET in Esophageal CancerWho this might be right forEsophageal Neoplasms St. James's Hospital, Ireland 250
Testing effectiveness (Phase 2)UnknownNCT02797626What this trial is testingTrial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)Who this might be right forStage II A/B Seminomatous Germ Cell Tumors Heinrich-Heine University, Duesseldorf 30
Not applicableStudy completedNCT03601689What this trial is testingPredictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal AdenocarcinomaWho this might be right forRectal Neoplasms Moroccan Society of Surgery 84
Not applicableActive Not RecruitingNCT06480617What this trial is testingObservational, Bivariate Analysis of Clinical Big Data in Patients With Cervical CancerWho this might be right forProgression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-upOverall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up Anhui Provincial Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT00118755What this trial is testingTwo Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 435
Not applicableLooking for participantsNCT05911802What this trial is testingPrognostic Analyses on a Validation Series of Patients With Waldenström's DiseaseWho this might be right forWaldenstrom's DiseasePrognostic Index French Innovative Leukemia Organisation 500
Testing effectiveness (Phase 2)UnknownNCT00839111What this trial is testingSorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentWho this might be right forColorectal Neoplasms Fudan University 43
Testing effectiveness (Phase 2)Ended earlyNCT00773383What this trial is testingThe Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 35
Testing effectiveness (Phase 2)WithdrawnNCT01174537What this trial is testingNew Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWho this might be right forGlioblastomaSarcomaNeuroblastoma Hadassah Medical Organization
Post-approval studies (Phase 4)UnknownNCT03986528What this trial is testingClinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNSCLC Jie Li 334
Early research (Phase 1)Study completedNCT01837095What this trial is testingDose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Polyphor Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01827111What this trial is testingPhase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 21
Not applicableStudy completedNCT07363434What this trial is testingA Real-world Study of Indian Patients With Advanced Breast Cancer Treated With RibociclibWho this might be right forBreast Cancer Novartis Pharmaceuticals 335
Early research (Phase 1)Ended earlyNCT02222363What this trial is testingStudy of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid TumorsWho this might be right forRefractory Cancer Vivolux AB 19
Not applicableStudy completedNCT00897533What this trial is testingDevelopment of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer ECOG-ACRIN Cancer Research Group 137
Testing effectiveness (Phase 2)UnknownNCT04664244What this trial is testingCombination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous CarcinomaWho this might be right forRecurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more Lei Li 43
Testing effectiveness (Phase 2)Ended earlyNCT00940875What this trial is testingTarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 54
Testing effectiveness (Phase 2)Study completedNCT00520403What this trial is testingAvastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.Who this might be right forRenal Cell Cancer Hoffmann-La Roche 25
Large-scale testing (Phase 3)Study completedNCT00338286What this trial is testingEpoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard ChemotherapyWho this might be right forBreast CancerNeoplasm Metastasis Janssen Research & Development, LLC 2,098